US Stock MarketDetailed Quotes

EWTX Edgewise Therapeutics

Watchlist

17.260
-0.220-1.26%

Trading May 14 12:57 ET

1.61BMarket Cap-11207P/E (TTM)

Edgewise Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-25.29%-28.6M

-74.69%-91.95M

-126.32%-26.83M

-84.39%-22.06M

-24.56%-20.23M

-81.56%-22.83M

-57.09%-52.64M

-25.86%-11.86M

-44.80%-11.96M

-66.29%-16.25M

Net income from continuing operations

-24.90%-28.53M

-48.08%-100.16M

-55.26%-30.14M

-46.95%-25.71M

-33.62%-21.47M

-55.78%-22.84M

-57.99%-67.64M

-52.92%-19.42M

-35.13%-17.5M

-55.19%-16.07M

Depreciation and amortization

117.84%525K

221.93%1.73M

479.35%533K

201.21%497K

199.35%461K

89.76%241K

97.79%538K

17.95%92K

157.81%165K

201.96%154K

Change In working capital

-16.47%-2.32M

-138.18%-1.56M

-103.66%-201K

-52.95%974K

87.72%-342K

-189.81%-1.99M

-11.75%4.09M

313.80%5.49M

-32.68%2.07M

-1,707.79%-2.78M

-Change in prepaid assets

82.45%-63K

-144.70%-3.55M

-235.84%-379K

-508.95%-1.16M

14.49%-1.66M

-190.20%-359K

39.30%-1.45M

163.27%279K

-117.92%-190K

34.16%-1.94M

-Change in payables and accrued expense

-19.68%-2.09M

-19.90%2.1M

-91.40%295K

88.68%2.23M

248.20%1.32M

-57.62%-1.75M

-62.72%2.62M

94.17%3.43M

-41.24%1.18M

-131.82%-888K

-Change in other current liabilities

-241.38%-164K

-103.56%-104K

-106.58%-117K

-109.57%-103K

--0

383.33%116K

--2.92M

--1.78M

--1.08M

--43K

Cash from discontinued investing activities

Operating cash flow

-25.29%-28.6M

-74.69%-91.95M

-126.32%-26.83M

-84.39%-22.06M

-24.56%-20.23M

-81.56%-22.83M

-57.09%-52.64M

-25.86%-11.86M

-44.80%-11.96M

-66.29%-16.25M

Investing cash flow

Cash flow from continuing investing activities

-647.10%-268.31M

245.78%102.89M

135.69%26.98M

188.97%23.42M

7,582.61%3.44M

56.25%49.04M

70.86%-70.58M

-635.34%-75.6M

16.73%-26.32M

99.97%-46K

Net PPE purchase and sale

93.20%-297K

-3.59%-5.75M

95.11%-161K

65.64%-457K

-37.00%-759K

-1,083.74%-4.37M

-730.24%-5.55M

-4,068.35%-3.29M

-194.90%-1.33M

-628.95%-554K

Net investment purchase and sale

-601.80%-268.01M

267.04%108.63M

137.54%27.14M

195.54%23.88M

726.97%4.2M

68.19%53.41M

73.08%-65.03M

-609.18%-72.3M

19.79%-24.99M

100.32%508K

Cash from discontinued investing activities

Investing cash flow

-647.10%-268.31M

245.78%102.89M

135.69%26.98M

188.97%23.42M

7,582.61%3.44M

56.25%49.04M

70.86%-70.58M

-635.34%-75.6M

16.73%-26.32M

99.97%-46K

Financing cash flow

Cash flow from continuing financing activities

1,147,866.67%241.07M

-58.99%53.17M

17,587.46%52.99M

-100.16%-211K

106.15%369K

-71.23%21K

-30.45%129.64M

-203.41%-303K

350,413.51%129.69M

119.98%179K

Net common stock issuance

--239.15M

-59.26%52.62M

9,580.72%52.62M

----

--0

-30.61%129.17M

---555K

----

Proceeds from stock option exercised by employees

9,071.43%1.93M

-1.66%713K

91.62%320K

-94.23%3K

-14.78%369K

-71.23%21K

101.39%725K

-43.00%167K

40.54%52K

6,085.71%433K

Net other financing activities

----

34.26%-165K

-42.35%49K

----

-102.42%-251K

--85K

---82K

----

Cash from discontinued financing activities

Financing cash flow

1,147,866.67%241.07M

-58.99%53.17M

17,587.46%52.99M

-100.16%-211K

106.15%369K

-71.23%21K

-30.45%129.64M

-203.41%-303K

350,413.51%129.69M

119.98%179K

Net cash flow

Beginning cash position

291.47%86.1M

41.29%21.99M

-69.97%32.96M

73.42%31.81M

39.99%48.23M

41.29%21.99M

-85.16%15.57M

938.19%109.75M

-63.61%18.34M

-84.41%34.45M

Current changes in cash

-312.80%-55.83M

897.42%64.1M

160.56%53.14M

-98.74%1.15M

-1.93%-16.42M

38.92%26.24M

107.19%6.43M

-1,856.84%-87.75M

329.47%91.41M

90.56%-16.11M

End cash Position

-37.25%30.26M

291.47%86.1M

-69.97%32.96M

73.42%31.81M

39.99%48.23M

41.29%21.99M

938.19%109.75M

-63.61%18.34M

Free cash flow

-6.26%-28.9M

-67.91%-97.69M

-78.18%-26.99M

-69.37%-22.52M

-24.97%-20.99M

-110.14%-27.19M

-70.24%-58.18M

-59.49%-15.15M

-52.57%-13.29M

-70.63%-16.8M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-25.29%-28.6M	-74.69%-91.95M	-126.32%-26.83M	-84.39%-22.06M	-24.56%-20.23M	-81.56%-22.83M	-57.09%-52.64M	-25.86%-11.86M	-44.80%-11.96M	-66.29%-16.25M
Net income from continuing operations	-24.90%-28.53M	-48.08%-100.16M	-55.26%-30.14M	-46.95%-25.71M	-33.62%-21.47M	-55.78%-22.84M	-57.99%-67.64M	-52.92%-19.42M	-35.13%-17.5M	-55.19%-16.07M
Depreciation and amortization	117.84%525K	221.93%1.73M	479.35%533K	201.21%497K	199.35%461K	89.76%241K	97.79%538K	17.95%92K	157.81%165K	201.96%154K
Change In working capital	-16.47%-2.32M	-138.18%-1.56M	-103.66%-201K	-52.95%974K	87.72%-342K	-189.81%-1.99M	-11.75%4.09M	313.80%5.49M	-32.68%2.07M	-1,707.79%-2.78M
-Change in prepaid assets	82.45%-63K	-144.70%-3.55M	-235.84%-379K	-508.95%-1.16M	14.49%-1.66M	-190.20%-359K	39.30%-1.45M	163.27%279K	-117.92%-190K	34.16%-1.94M
-Change in payables and accrued expense	-19.68%-2.09M	-19.90%2.1M	-91.40%295K	88.68%2.23M	248.20%1.32M	-57.62%-1.75M	-62.72%2.62M	94.17%3.43M	-41.24%1.18M	-131.82%-888K
-Change in other current liabilities	-241.38%-164K	-103.56%-104K	-106.58%-117K	-109.57%-103K	--0	383.33%116K	--2.92M	--1.78M	--1.08M	--43K
Cash from discontinued investing activities
Operating cash flow	-25.29%-28.6M	-74.69%-91.95M	-126.32%-26.83M	-84.39%-22.06M	-24.56%-20.23M	-81.56%-22.83M	-57.09%-52.64M	-25.86%-11.86M	-44.80%-11.96M	-66.29%-16.25M
Investing cash flow
Cash flow from continuing investing activities	-647.10%-268.31M	245.78%102.89M	135.69%26.98M	188.97%23.42M	7,582.61%3.44M	56.25%49.04M	70.86%-70.58M	-635.34%-75.6M	16.73%-26.32M	99.97%-46K
Net PPE purchase and sale	93.20%-297K	-3.59%-5.75M	95.11%-161K	65.64%-457K	-37.00%-759K	-1,083.74%-4.37M	-730.24%-5.55M	-4,068.35%-3.29M	-194.90%-1.33M	-628.95%-554K
Net investment purchase and sale	-601.80%-268.01M	267.04%108.63M	137.54%27.14M	195.54%23.88M	726.97%4.2M	68.19%53.41M	73.08%-65.03M	-609.18%-72.3M	19.79%-24.99M	100.32%508K
Cash from discontinued investing activities
Investing cash flow	-647.10%-268.31M	245.78%102.89M	135.69%26.98M	188.97%23.42M	7,582.61%3.44M	56.25%49.04M	70.86%-70.58M	-635.34%-75.6M	16.73%-26.32M	99.97%-46K
Financing cash flow
Cash flow from continuing financing activities	1,147,866.67%241.07M	-58.99%53.17M	17,587.46%52.99M	-100.16%-211K	106.15%369K	-71.23%21K	-30.45%129.64M	-203.41%-303K	350,413.51%129.69M	119.98%179K
Net common stock issuance	--239.15M	-59.26%52.62M	9,580.72%52.62M	----	----	--0	-30.61%129.17M	---555K	----	----
Proceeds from stock option exercised by employees	9,071.43%1.93M	-1.66%713K	91.62%320K	-94.23%3K	-14.78%369K	-71.23%21K	101.39%725K	-43.00%167K	40.54%52K	6,085.71%433K
Net other financing activities	----	34.26%-165K	-42.35%49K	----	----	----	-102.42%-251K	--85K	---82K	----
Cash from discontinued financing activities
Financing cash flow	1,147,866.67%241.07M	-58.99%53.17M	17,587.46%52.99M	-100.16%-211K	106.15%369K	-71.23%21K	-30.45%129.64M	-203.41%-303K	350,413.51%129.69M	119.98%179K
Net cash flow
Beginning cash position	291.47%86.1M	41.29%21.99M	-69.97%32.96M	73.42%31.81M	39.99%48.23M	41.29%21.99M	-85.16%15.57M	938.19%109.75M	-63.61%18.34M	-84.41%34.45M
Current changes in cash	-312.80%-55.83M	897.42%64.1M	160.56%53.14M	-98.74%1.15M	-1.93%-16.42M	38.92%26.24M	107.19%6.43M	-1,856.84%-87.75M	329.47%91.41M	90.56%-16.11M
End cash Position	-37.25%30.26M	291.47%86.1M	291.47%86.1M	-69.97%32.96M	73.42%31.81M	39.99%48.23M	41.29%21.99M	41.29%21.99M	938.19%109.75M	-63.61%18.34M
Free cash flow	-6.26%-28.9M	-67.91%-97.69M	-78.18%-26.99M	-69.37%-22.52M	-24.97%-20.99M	-110.14%-27.19M	-70.24%-58.18M	-59.49%-15.15M	-52.57%-13.29M	-70.63%-16.8M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall